Abstract
Cytokines are soluble, non-antibody proteins that orchestrate many immunological reactions including cell-mediated immune responses; lymphocyte activation, proliferation and differentiation; and haemopoietic mechanisms. The term encompasses the mediators derived from activated T-lymphocytes, i.e. lymphokines (LKs) (DUMONDE et al. 1969); monocytes/macrophages, i.e. monokines (MKs) (WAKSMAN and NAMBA 1976); and those mediators whose cellular origin is known to be more diverse, e.g. interferons. All cytokines were originally described in terms of their biological activity(ies) with little knowledge of their chemical structure. From the application of more precise biological assays, immunoassays, and more sensitive biochemical techniques, it became apparent that different lymphokine or cytokine activities could actually be mediated by the same molecule(s). Consequently, at the 2nd International Workshop on Lymphokines in 1979, the generic term “interleukin” (“between leucocytes”) was introduced to bring together some of these mediators (AARDEN et al. 1979). Historically, the concept of special mediators of immunological regulation, rather than direct cellular or anti-body-mediated mechanisms, evolved from studies of delayed-type hypersensitivity and inflammation, and has been extensively documented (ADELMAN et al. 1979; ROCKLIN et al. 1980; WATSON 1981; HANSON et al. 1982; DUMONDE and HAMBLIN 1983).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aarden LA, Brimner TK, Cerottini JC et al. (1979) Letter to the editor: revised nomenclature for antigen non-specific T-cell proliferation and helper factors. J Immunol 123:2928–2929
Adelman NE, Hammond ME, Cohen S, Dvorak HF (1979) Lymphokines as inflammatory mediators. In: Cohen S, Pick E, Oppenheim JJ (eds) Biology of the lymphokines. Academic, New York, pp 13–58
Albrightson CR, Baenziger NL, Needleman P (1985) Exaggerated human vascular cell prostaglandin biosynthesis mediated by monocytes: role of monokines and interleukin 1. J Immunol 135:1872–1877
Alcocer-Varela J, Alarcon-Segovia D (1982) Decreased production of and response to interleukin-2 by cultured lymphocytes from patients with systemic lupus erythematosus. J Clin Invest 69:1388–1396
Alcocer-Varela J, Martinez-Cordero E, Alarcon-Segovia D (1985) Spontaneous production of, and defective response to, interleukin-1 by peripheral blood mononuclear cells from patients with scleroderma. Clin Exp Immunol 59:666–672
Allison AC, Denman AM, Barnes RD (1971) Cooperating and controlling functions of thymus-derived lymphocytes in relation to autoimmunity. Lancet II:135–140
Ansel J, Luger TA, Green I (1983) The effect in vitro and in vivo of UV irradiation on the production of ETAF activity by human and murine keratinoeytes. J Invest Dermatol 81:519–523
Ansel J, Luger TA, Klock A, Hochstein D, Green I (1984) The effect of in vivo UV irradiation on the production of IL-1 by murine macrophages and P388D1 cells. J Immunol 133:1350–1355
Ansel JC, Luger TA, Lowry DR, Mountz JD (1986) Expression of IL-1 in murine kerati-noeytes. J Invest Dermatol 87:127
Ansel JC, Luger TA, Green I (1987) Fever and increased serum IL-1 activity as a systemic manifestation of acute phototoxicity in New Zealand white rabbits. J Invest Dermatol 89:32–37
Bell TV, Harley CB, Stetsko D, Sander DN (1987) Expression of mRNA homologous to interleukin 1 in human epidermal cells. J Invest Dermatol 88:375–379
Belsito DV, Dersarkissian RM, Thorbecke GJ, Baer RL (1987) Reversal by lymphokines of the age-related hyperresponsiveness to contact sensitization and reduced la expression on Langerhans cells. Arch Dermatol Res 279:576–580
Bevilacqua MP, Pober JS, Wheeler MC, Contran RS, Gimbrone MA Jr (1985) Interleukin 1 acts on cultured human vascular endothelium to increase the adhesion of polymorphonuclear leukocytes, monocytes and related leukocyte lines. J Clin Invest 76:2003–2011
Billiau A (1986) BSF-2 is not just a differentiation factor. Nature 324:415
Boker BS, Swain AF, Fry L, Valdimarsson H (1984) Epidermal T lymphocytes and HLA-DR expression in psoriasis. Br J Dermatol 110:555–564
Borel JF, Feurer C, Magnee C, Stahelin H (1977) Effects of the new antilymphocyte peptide cyclosporin A in animals. Immunology 32:1017–1025
Bos JD, Krieg SR (1985) Psoriasis infiltrating cell immunophenotype: changes induced by PUVA or corticosteroid treatment in T-cell subsets, Langerhans cells and interdigitating cells. Acta Derm Venereol (Stockh) 65:390–397
Brain S, Camp R, Dowd P, Kobza Black A, Greaves MW (1984) The release of leukotriene B4-like material in biologically active amounts from the lesional skin of patients with psoriasis. J Invest Dermatol 83:70–77
Camp RDR, Fincham NJ, Cunningham FM, Greaves MW, Morris J, Chu A (1986) Psoriatic skin lesions contain biologically active amounts of an interleukin 1-like compound. J Immunol 137:3469–3474
Carvalho EM, Badaro R, Reed SG, Jones TC, Johnson WD (1985) Absence of gamma interferon and interleukin 2 production during active visceral leishmaniasis. J Clin Invest 76:2066–2069
Cavender DE, Haskard DO, Joseph B, Ziff M (1986) Interleukin 1 increases the binding of human B and T lymphocytes to endothelial cell monolayers. J Immunol 136:203–207
Clark SC, Kamen R (1987) The human hematopoietic colony stimulating factors. Science 236:1229–1237
Clark-Lewis I, Aebersold R, Ziltener H, Schrader JW, Hood LE, Kent SBH (1986) Automated chemical synthesis of a protein growth factor for hemopoietic cells, interleukin-3. Science 231:134–139
Cybulsky MI, Colditz IG, Movat HZ (1985) Interleukin 1 activity in the local recruitment of PMNs: its potential role in endotoxin induced acute inflammation. Fed Proc 44:1260 (abstr)
Danner M, Luger TA (1987) Human keratinocytes and epidermoid carcinoma cell lines produce a cytokine with interleukin 3-like activity. J Invest Dermatol 88:353–361
Dauphine MJ, Kipper BS, Wolfsy D, Talal N (1981) Interleukin-2 deficiency is a common feature of autoimmune mice. J Immunol 127:2483–2487
Dayer JM (1982) Effects of retinoids on prostaglandin E2 (PGE2) and mononuclear cell factor (MCF) production by human monocyte cultures. Clin Res 30:469 (abstr)
Dayne R, Samlowski WE, Burnhan DK, Gahring LC, Roberts LK (1986) Immunobiological consequences of acute and chronic UV exposure. Curr Probl Dermatol 15:177–194
Dinarello CA (1984 a) Interleukin 1. Rev Infect Dis 6:51–55
Dinarello CA (1984 b) Interleukin 1 and the pathogenesis of the acute-phase response. N Engl J Med 311:1413–1418
Dower SK, Urdel DL (1987) The interleukin-1 receptor. Immunol Today 8:46–51
Drebin AJ, Schatten S, Tominga A (1983) Effect of ultraviolet radiation-induced impairment of antigen-presenting cell function at the cellular and molecular level. In: Parrish JA (ed) The effect of ultraviolet radiation on the immune system. Johnson and Johnson, New York, p 123
Dumonde DC, Wolstencroft RA, Panayi GS, Matthew M, Morley J, Howson WT (1969) Lymphokines: non-antibody mediators of cellular immunity generated by lymphocyte activation. Nature 224:38–42
Dumonde DC, Hamblin AS (1983) Lymphokines. In: Holborow EJ, Reeves WG (eds) Immunology in medicine, 2nd edn. Academic, New York, pp 121–150
Durum SK, Schmidt JA, Oppenheim JJ (1985) Interleukin 1: an immunological perspective. Ann Rev Immunol 3:263–287
Elliot YF, Lin Y, Mizel SB, Blackley RC, Harnish DG, Paetkau Y (1984) Induction of interleukin 2 messenger RNA inhibited by cyclosporin A. Science 226:1439–1441
Elments C, Rick E, Urda G, Fujiwara H, Ellner J (1986) UVB radiation inhibits accessory cell signals required for mitogenic responses of human T lymphocytes. J Invest Dermatol 86:473 (abstr)
Fung MC, Hapel AJ, Ymer S, et al. (1984) Molecular cloning of cDNA for murine inter-leukin 3. Nature 307:233–237
Gahring L, Baltz M, Pepys MB, Daynes R (1984) Effect of ultraviolet radiation on the production of epidermal cell thymocyte-activating factor/interleukin 1 in vivo and in vitro. Proc Natl Acad Sci USA 81:1198–1202
Gahring LC, Daynes RA (1986) Desensitization of animals to the inflammatory effects of ultraviolet radiation is mediated through mechanisms which are distinct from those responsible for endotoxin tolerance. J Immunol 136:2868–2874
Gery I, Gershon RK, Waksman BH (1971) Potentiation of cultured mouse thymocyte responses by factors released by peripheral leukocytes. J Immunol 107:1778
Gery I, Davies P, Derr J, Krett N, Barranger JA (1981) Relationship between production and release of lymphocyte-activating factor (interleukin 1) by murine macrophages. I. Effects of various agents. Cell Immunol 64:293–303
Gilchrist BA, Sauder DN (1984 a) Autocrine growth stimulation of human keratinocytes by epidermal cell-derived thymocyte activating factor (ETAF): implications for cellular ageing. J Invest Dermatol 82:439 (abstr)
Gilchrist BA, Sauder DN (1984 b) Autocrine growth stimulation of human keratinocytes by epidermal cell-derived thymocyte activating factor (ETAF): implications for cellular ageing. Clin Res 32:585A
Gillis S, Stull DD (1982) Tumor and hybridoma cell line interleukin-2 production. In: Pick E (ed) Lymphokines, vol 5. Academic, New York, pp 371–385
Gillis S, Watson J (1980) Biochemical and biological characterization of lymphocyte regulatory molecules. V. Identification of an interleukin-2 producer human leukemic T-cell line. J Exp Med 152:1709–1719
Gillis S, Scheid M, Watson J (1980) Biochemical and biological characterization of lymphocyte regulatory molecules. III. The isolation and phenotypic characterization of interleukin-2 producing T-cell lymphomas. J Immunol 125:2570–2578
Gordon J, MacLean LD (1965) A lymphocyte-stimulating factor produced in vitro. Nature 208:795–796
Gray PW, Leung DW, Pennica D, et al. (1982) Expression of human immune interferon cDNA in E. coli and monkey cells. Nature 295:503–508
Greene MI, Sy MS, Kripke ML, Benacerraf B (1979) Impairment of antigen-presenting function by ultraviolet radiation. Proc Natl Acad Sci USA 76:6591–6595
Hanifin JM, Lobitz WC Jr (1977) Newer concepts of atopic dermatitis. Arch Dermatol 113:667–670
Hanson JM, Rumjanek VM, Morley J (1982) Mediators of cellular immune reactions. Pharmacol Ther 17:165–198
Harber LC, Bickers DR (1981) Photosensitivity diseases. Principles of diagnosis and management. Saunders, Philadelphia
Harper JI, Keat ACS, Staughton RCD (1984) Cyclosporin for psoriasis. Lancet 11:981–988
Hauser C, Saurat JH, Schmitt A, et al. (1986) Interleukin 1 is present in normal human epidermis. J Immunol 136:3317–3322
Hawk JLM, Black AK, Jaenicke KF, et al. (1983) Increased concentrations of arachidonic acid, prostaglandin E2, D2 and 6-oxo-F1α and histamine in human skin following UVA irradiation. J Invest Dermatol 80:476–498
Hirano T, Yasukawa K, Harada H, et al. (1986) Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin. Nature 324:73–76
Holbrook NJ, Smith KA, Fornace AJ, Comeau CC, Wiskocil RL, Crabtree GR (1984) T-cell growth factor: complete nucleotide sequence and organisation of the gene in normal and malignant cells. Proc Natl Acad Sci USA 81:1634–1638
Howard M, Farrar J, Hilfiker M, et al. (1982) Identification of a T-cell derived B-cell growth factor distinct from interleukin 2. J Exp Med 155:914–923
Ihle JN, Rebar L, Keller J, Lee JC, Hapel AJ (1982) Interleukin 3: possible roles in the regulation of lymphocyte differentiation and growth. Immunol Rev 63:11–32
Kampschmidt RF, Pulliam LA, Merriman CR (1978) Further similarities of endogenous pyrogen and leukocytic endogenous mediator. Am J Physiol 243:E332–E337
Kasakura S, Lowenstein L (1965) A factor stimulating DNA synthesis derived from the medium of leucocyte cultures. Nature 208:794–795
Kermani-Arob V, Hirji K, Ahmed AR, Fahey JL (1984) Deficiency of interleukin-2 production and interleukin-2 receptor expression on peripheral blood leukocytes after phytohaemagglutinin stimulation in pemphigus. J Invest Dermatol 83:101–104
Kinashi T, Harada N, Severinson E, et al. (1986) Cloning of complementary DNA encoding T-cell replacing factor and identity with B-cell growth factor II. Nature 324:70–73
Kobayashi Y, Asada M, Higuchi M, Osawa T (1982) Human T-cell hybridomas producing lymphotoxin and migration inhibitory factor. J Immunol 128:417–422
Kragballe K, Marcelo CL, Voorhees J J, Sauder DN (1987) Formation of epidermal cell thymocyte-activating factor (ETAF) from cultured human keratinoeytes from normal and uninvolved psoriatic skin. J Invest Dermatol 88:8–10
Kunkell SL, Chensue SW (1985) Arachidonic acid metabolites regulate interleukin-1 production. Biochem Biophys Res Commun 128:892–897
Kuntz-Crow M, Kunkel MG (1982) Human dendritic cells: major stimulators of the autologous and allogeneic mixed leucocyte reactions. Clin Exp Immunol 49:338–346
Kupper TS, McGuire J (1986) Hydrocortisone reduces both constitutive and UV-elicted release of epidermal thymocyte activating factor (ETAF) by cultured keratinoeytes. J Invest Dermatol 87:570–573
Kupper T, Gubler U, Ballard D, et al. (1986) Identification of interleukin 1 mRNA in human and murine keratinocyte. Clin Res 34:640–647
Leonard WJ, Depper JM, Crabtree GR, et al. (1984) Molecular cloning and expression of cDNAs for the human interleukin-2 receptor. Nature 311:626–631
Leung DYM, Saryan JA, Frankel R, Lareau M, Geha RS (1983) Impairment of the autologous mixed lymphocyte reaction in atopic dermatitis. J Clin Invest 72:1482–1486
Liang S-M, Thatcher DR, Wang C-M, Allet B (1986) Studies of structure-activity relation-ships of human interleukin-2. J Biol Chem 261:334–337
Linker-Israeli M, Bahke AC, Kitridou RC, Gendler S, Gillis S, Horwitz DA (1983) Defective production of interleukin-1 and interleukin-2 in patients with systemic lupus erythematosus (SLE). J Immunol 130:2651–2655
Lomedico PT, Gubler U, Hellmann CP, et al. (1984) Cloning and expression of murine interleukin-1 cDNA in Escherichia coli. Nature 312:458–462
Lopez AF, Begley CG, Williamson DJ, et al. (1986) Murine eosinophil differentiation factor. An eosinophil-specific colony-stimulating factor with activity for human cells. J Exp Med 163:1085–1099
Lotze MT, Matory YL, Ettinghausen SE, et al. (1985) In vivo administration of purified human interleukin 2. II. Half-life, immunologic effects, and expansion of peripheral lymphoid cells in vivo with recombinant IL-2. J Immunol 135:2865–2875
Luger TA, Oppenheim J J (1983) Characteristics of interleukin 1 and epidermal cell-derivedthymocyte activating factor. Adv Inflam Res 5:1–25
Luger TA, Stadler BM, Katz SI, et al. (1981) Epidermal cell (keratinocyte)-derived thymocyte-activating factor (ETAF). J Immunol 127:1493–1498
Luger TA, Sztein MB, Schmidt J, et al. (1983 a) Properties of murine and human epidermal cell-derived thymocyte-activating factor. Fed Proc 42:2772–2776
Luger TA, Charon J A, Colot M, et al. (1983 b) Chemo tactic properties of partially purified human epidermal cell-derived thymocyte-activating factor (ETAF) for polymorphonuclear and mononuclear cells. J Immunol 131:816–820
Luger TA, Wirth U, Koeck A (1985) Epidermal cells synthesize a cytokine with interleukin 3 like properties. J Immunol 134:915–919
Maini RN, Bryceson ADM, Wolstencroft RA, Dumonde DC (1969) Lymphocyte mitogenic factor in man. Nature 224:43–44
Majwski S, Tigalonowa M, Jablonska S, Polakowski I, Janczura E (1987) Serum samples from patients with active psoriasis enhance lymphocyte-induced angiogenesis and modulate endothelial cell proliferation. Arch Dermatol 123:221–225
Mallet AI, Cunningham FM (1985) Structural determination of platelet activating factor in psoriasis. Biochem Biophys Res Commun 126:192–199
March CJ, Mosley B, Larsen A, et al. (1985) Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs. Nature 315:641–647
McGuire J, Longdon R, Kupper T (1986) Interleukin-1 mRNA increases following irradiation with ultraviolet-B. J Invest Dermatol 87:155 (abstr)
Metcalf D (1985) The granulocyte-macrophage colony stimulating factors. Science 229:16–22
Miossec P, Yu C-L, Ziff M (1984) Lymphocyte chemotactic activity of human interleukin 1. J Immunol 133:2007–2011
Miossec P, Cavender D, Ziff M (1986) Production of interleukin 1 by human endothelial cells. J Immunol 136:2486–2491
Mizoguchi M, Furusawa S, Okitsu S, Yoshino K (1985) Macrophage-derived interleukin 1 activity in atopic dermatitis. J Invest Dermatol 84:303–311
Namiuchi S, Kumagai S, Sano H, et al. (1986) A human T cell line established from a patient with Sezary syndrome. J Immunol Methods 94:215–224
Nikaido T, Shimizu A, Ishida N, et al. (1984) Molecular cloning of cDNA encoding human interleukin-2 receptor. Nature 311:631–635
Noonan FP, Kripke ML, Pederson GM, Green MI (1981) Suppression of contact sensitivity of mice by ultraviolet radiation is associated with defective antigen presentation. Immunology 43:527–533
Oppenheim JJ, Kovacs EJ, Matsushima K, Durum SK (1986) There is more than one interleukin 1. Immunol Today 7:45–56
Parrish JA, Kripki ML, Warwick ML (1984) Photoimmunology. Plenum, New York
Pennica D, Nedwin GE, Haylick JS, et al. (1984) Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin. Nature 312:724–729
Pincus H, Mehregan AM (1966) The primary histological lesion of seborrhaeic dermatitis and psoriasis. J Invest Dermatol 46:109–116
Pober JS, Bevilacqua MP, Mendrick DL, Lapierre LA, Fiers W, Gimbrone MA Jr (1986) Two distinct monokines, interleukin 1 and tumor necrosis factor, each independently induce biosynthesis and transient expression of the same antigen on the surface of cultured human vascular endothelial cells. J Immunol 136:1680–1687
Pohlman TH, Stanness KA, Beatty PG, Ochs MD, Harlan JM (1986) An endothelial cell surface factor(s) induced in vitro by lipopolysaccharide, interleukin 1, and tumour necrosis factor — increases neutrophil adherence by a CDW 18-dependent mechanism. J Immunol 136:4548–4553
Politstein-Willinger E (1985) Normalization of defective interleukin 1 and interleukin 2 production in patients with pemphigus vulgaris following chrysotherapy. Clin Exp Immunol 62:705–714
Rasanen L, Lehto M, Reunola T, Jansen C, Lehtinen M, Leinikki P (1987 a) Langerhans cell- and T-lymphocyte functions in patients with atopic dermatitis with disseminated cutaneous herpes simplex virus infection. J Invest Dermatol 89:15–18
Rasanen L, Lehto M, Reunala T, Jansen C, Leinikki P (1987 b) Decreased monocyte production of interleukin-1 and impaired lymphocyte proliferation in atopic dermatitis. Arch Dermatol Res 279:215–218
Robb RJ, Smith KA (1981) Heterogeneity of human T-cell growth factor(s) due to variable glycosylation. Mol Immunol 18:1087–1094
Robb RJ (1984) Interleukin 2: the molecule and its function. Immunol Today 5:203–209
Robb RJ, Kutny RM, Panico M, Morris HR, Chowdrey V (1984) Amino acid sequence and post-translational modification of human interleukin-2. Proc Natl Acad Sci USA 81:6456–6490
Robertson B, Gahring L, Newton R, Daynes R (1987) In vivo administration of interleukin 1 to normal mice depresses their capacity to elicit contact hypersensitivity responses: prostaglandins are involved in this modification of immune function. J Invest Dermatol 88:380–387
Rocklin RE, Bendtzen K, Greineder D (1980) Mediators of immunity: lymphokines and monokines. Adv Immunol 29:55–136
Rosenberg SA, Grimm EA, McGrogan M, et al. (1984) Biological activity of recombinant human interleukin-2 produced in Escherichia coli. Science 223:1412–1415
Rosenstreich DL, Wahl SM (1979) Cellular sources of lymphokines. In: Cohen S, Pick E, Oppenheim JJ (eds) Biology of the lymphokines. Academic, New York, pp 210–242
Rosenwasser LJ, Dinarello CA, Rosenthal AS (1979) Adherent cell function in murine T-lymphocyte antigen recognition. IV. Enhancement of murine T cell antigen recognition by human leukocytic pyrogen. J Exp Med 150:709–714
Rullan PP, Barr RJ, Cole GW (1984) Cyclosporine and murine allergic contact dermatitis. Arch Dermatol 120:1179–1186
Sagar AD, Sehgal PB, Slate DL, Ruddle FH (1982) Multiple human interferon genes. J Exp Med 156:744–755
Sakane T, Suzuki N, Ueda Y, et al. (1986) Analysis of interleukin-2 activity in patients with Behcet’s disease. Arthritis Rheum 29:371–378
Sandborg CI, Berman MA, Andrews BS, Friou GJ (1985) Interleukin-1 production by mononuclear cells from patients with scleroderma. Clin Exp Immunol 60:294–302
Sandborg CI, Berman MA, Andrews BS, Mirick GR, Friou GJ (1986) Increased production of an interleukin 1 (IL-1) inhibitor with fibroblast stimulating activity by mononuclear cells from patients with scleroderma. Clin Exp Immunol 66:312–319
Sauder DN, Katz SI (1982) Immune modulation by epidermal cell products: possible role of ETAF in inflammatory and neoplastic skin diseases. J Am Acad Dermatol 7:651–654
Sauder DN, Dinarello CA, Morhenn VB (1984) Langerhans cell production of interleukin-1. J Invest Dermatol 82:605–607
Schimpl A, Wecker E (1972) Replacement of T-cell function by a T-cell product. Nature 237:15–17
Schleimer RP, Rutledge BK (1986) Cultured human vascular endothelial cells acquire adhesiveness for neutrophils after stimulation with interleukin 1, and tumour-promoting phorbol diesters. J Immunol 136:649–654
Schmitt A, Hauser C, Janin F, Dayer JM, Saurat JH (1986) Normal rat epidermis contains high amounts of natural tissue IL-1. Biochemical analysis by HPLC identifies a MW17 Kd form with a pI 5.7 and a MW 30 Kd form. Lymphokine Res 5:105–117
Schmitt A, Hauser C, Didierjean L, Merot Y, Dayer JM, Saurat JH (1987) Systemic administration of detretinate increases epidermal interleukin 1 in the rat. Br J Dermatol 116:615–622
Schrader JW, Clark-Lewis I (1981) T-cell hybridoma-derived regulatory factors. I. Production of T-cell growth factor following stimulation with concanavalin A. J Immunol 126:1101–1105
Schroder JM, Christophers E (1985) Identification of a new and potent chemotaxin in psoriatic scales. J Invest Dermatol 84:444–451
Schwarz T, Urbanska A, Gschnait F, Luger TA (1986) Inhibition of the induction of contact hypersensitivity by an UV mediated epidermal cytokine. J Invest Dermatol 87:289
Schwarz T, Urbanska A, Gschnait F, Luger T (1987) Biological and biochemical properties of an UVB induced cell derived inhibitor of CHS. J Immunol 138:1457–1464
Seigel LJ, Harper ME, Wong-Staal F, Gallo RC, Nash WG, O’Brien SJ (1984) Gene for T-cell growth factor: location on human chromosome 4q and feline chromosome B1. Science 223:175–178
Shidani B, Milon G, Marchal G, Truffa-Bachi P (1984) Cyclosporin A inhibits the delayed-type hypersensitivity reaction: impaired production of early pro-inflammatory mediator(s). Eur J Immunol 14:314–318
Sieff CA, Tsai S, Faller DV (1987) Interleukin 1 induces cultured human endothelial cell production of granulocyte-macrophage colony-stimulating factor. J Clin Invest 79:48–51
Smith KA (1984) Interleukin 2. Ann Rev Immunol 2:319–333
Smith KA (1987) The two-chain structure of high affinity IL-2 receptors. Immunol Today 8:11–13
Smolen JS, Chused TM, Novotny EA, Steinberg AD (1982) The human autologous mixed lymphocyte reaction. J Immunol 129:1050–1053
Swain SL, Howard M, Kappler J, et al. (1983) Evidence for two distinct classes of murine B cell growth factors which have activities in different functional assays. J Exp Med 158:822–835
Tagami H, Ofiyi S (1976) Leukotactic properties of soluble substances in psoriasis scale. Br J Dermatol 95:1–8
Takematsu M, Suzuki R, Tagami H, Kumagai K (1986) Interleukin-1 like activity in horny layer extracts: decreased activity in scale extracts of psoriasis and sterile pustular dermatosis. Dermatologica 172:236–240
Taniguchi T, Matsui H, Fujita T, et al. (1983) Structure and expression of a cloned cDNA for human interleukin-2. Nature 302:305–310
Ternowitz T (1986) Monocyte and neutrophil chemotaxis in psoriasis. Relation to the clinical status and the type of psoriasis. J Am Acad Dermatol 15:1191–1199
Tew J-Y, Thorbecke GJ, Steinman RM (1981) Dendritic cells in the immune response: characteristics and recommended nomenclature. J Reticuloendothel Soc 31:371–380
Trechsel U, Evequoz V, Fleisch H (1985) Stimulation of interleukin 1 and 3 production by retinoic acid in vitro. Biochem J 230:339–344
Umetsu DT, Pober JS, Jabova HH, et al. (1985) Human dermal fibroblasts present tetanus toxoid antigen to antigen-specific T cell clones. J Clin Invest 76:254–260
Van Hooff JP, Leunissen RML, Staak WVD (1985) Cyclosporin and psoriasis. Lancet 1:335–342
Van Joost T, Heule F, Stolz E, et al. (1986) Short-term use of cyclosporin A in severe psoriasis. Br J Dermatol 114:615–620
Van Joost T, Stolz E, Heule F (1987) Efficacy of low-dose cyclosporine in severe atopic skin disease. Arch Dermatol 123:166–167
Veninga TS, de Doer JC (1986) Urinary excretion pattern of serotonin and 5-hydroxyin-dole acetic acid in ultraviolet induced erythema. J Invest Dermatol 50:1–8
Wainberg MA, Portnoy JD, Clecner B, et al. (1985) Viral inhibition of lymphocyte proliferative responsiveness in patients suffering from recurrent lesions caused by Herpes Simplex virus. J Infect Dis 152:441–448
Waksman BH, Namba Y (1976) On soluble mediators of immunologic regulation. Cell Immunol 21:161–176
Walsh LJ, Seymour GJ, Powel RN (1985) The in vitro effect of retinol on human gingival epithelium. II. Modulation of Langerhans cell markers and interleukin-1 production. J Invest Dermatol 85:501–506
Wang A, Lu S-D, Mark DF (1984) Site-specific mutagenesis of the human interleukin-2 gene: structure-function analysis of the cysteine residues. Science 224:1421–1433
Watson JS (1981) Lymphokines and the induction of immune responses. Transplantation 31:313–317
Wentzell JM, Baughman RD, O’Connor GT, Bernier GM (1987) Cyclosporine in the treatment of psoriasis. Arch Dermatol 123:163–165
Whiteside TL, Worrall JG, Buckingham RB, Rodnan GP (1987) Soluble mediators from mononuclear cells increase the synthesis of glycosaminoglycan by dermal fibroblast cultures derived from normal subjects and progressive systemic sclerosis patients. Arthritis Rheum 28:188–197
Widmer MB, Grabstein KH (1987) Regulation of cytolytic T-lymphocyte generation by B-cell stimulatory factor. Nature 326:795–798
Wolfsy D, Murphy ED, Roths JB, Dauphine MJ, Kipper SB, Talal N (1981) Deficient IL-2 activity in MRL/MP and C57B2/6J mice bearing the lpr gene. J Exp Med 154:1671–1680
Yokota T, Otsuka T, Mosmann T, et al. (1986) Isolation and characterization of a human interleukin cDNA clone, homologous to mouse B-cell stimulatory factor 1, that expresses B-cell- and T-cell-stimulating activities. Proc Natl Acad Sci USA 83:5894–5898
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Brown, K.A., Ellis, B.A., Dumonde, D.C. (1989). Cytokines in Relation to Inflammatory Skin Disease. In: Greaves, M.W., Shuster, S. (eds) Pharmacology of the Skin I. Handbook of Experimental Pharmacology, vol 87 / 1. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-73797-8_17
Download citation
DOI: https://doi.org/10.1007/978-3-642-73797-8_17
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-73799-2
Online ISBN: 978-3-642-73797-8
eBook Packages: Springer Book Archive